文献速递腹部介入CTUS

使用组织碎化术进行非侵入性胰腺消融:在体猪模型的临床前安全性研究

Non-Invasive Pancreas Ablation Using Histotripsy: Pre-clinical Safety Study in an In Vivo Porcine Model.
PubMed 文献 · Ultrasound Med Biol · 2025-10-03

本研究在9只健康猪中应用超声引导的组织碎化术进行胰腺消融,术后存活1周(n=3)或5周(n=6)。即刻CT显示病灶尺寸与计划1.5 cm球形治疗体积相符;5周时3只猪病灶分别缩小49%、98%、100%。组织碎化术耐受良好,9只中6只成功靶向胰腺,但3只因超声显示不佳出现肠道损伤。

要点

  • 组织碎化术可在超声引导下非侵入性靶向猪胰腺,即刻CT可见治疗区病灶。
  • 病灶尺寸与计划1.5 cm球形治疗体积相符,5周时部分病灶明显缩小。
  • 超声显示不佳可致肠道损伤等偏离靶点效应,需确保器官清晰显示气泡云位于组织内。

核心结论

  • 当器官清晰显示且气泡云保持在组织内时,组织碎化术似乎是胰腺治疗的可行方法。

研究设计与样本

  • 临床前在体猪模型研究,共9只健康猪接受超声引导的组织碎化术胰腺消融,术后存活1周(n=3)或5周(n=6),采用大体形态学、组织学分析和计算机断层扫描成像评估胰腺及周围组织损伤。

关键影像表现/征象

  • 即刻术后CT可见治疗区,病灶在前后径、横径和头尾径上分别测量为1.4±0.6 cm、1.2±0.3 cm和1.5±0.4 cm,与计划1.5 cm直径球形治疗体积相符。
  • 5周时3只猪观察到病灶缩小,分别减小49%、98%和100%。
  • 组织碎化术耐受良好,9只中6只成功靶向胰腺,注意到2例潜在胰腺炎。
  • 3只猪因超声显示不佳出现肠道损伤,导致偏离靶点效应包括感染性腹膜炎和胃肠道阻塞。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic cancer is an aggressive disease that is typically diagnosed late, leading to poor prognosis and overall survival. Even with advances in treatment, the 5-year survival rate for patients is only 12.5%. Histotripsy is a non-invasive, non-thermal and non-ionizing focused ultrasound treatment method that has recently been US FDA approved for treating liver tumors and is currently being investigated for other applications. This study expands on prior work investigating the feasibility of pancreas ablation using ultrasound-guided histotripsy in pigs. Here, we applied histotripsy to healthy pancreas in nine pigs using a therapy system with treatments guided by real-time ultrasound imaging. After treatment, subjects survived for 1 week (n = 3) or 5 weeks (n = 6). Damage to the pancreas and surrounding tissue was characterized using gross morphology, histological analysis, and computed tomography imaging. Treatment zones were visible on immediate post-procedure computed tomography, with lesion dimensions measuring 1.4 ± 0.6 cm, 1.2 ± 0.3 cm, and 1.5 ± 0.4 cm in the anteroposterior, transverse, and craniocaudal planes, aligning with the planned 1.5 cm-diameter spherical treatment volume. At 5 weeks, lesion size reduction was observed in three subjects, decreasing by 49%, 98%, and 100%, respectively. Histotripsy was well-tolerated, with successful pancreas targeting in six of nine subjects. Two cases of potential pancreatitis were noted. Three pigs experienced bowel damage due to poor ultrasound visualization, leading to off-target effects including septic peritonitis and gastrointestinal blockage. These findings suggest histotripsy is a viable approach for pancreatic treatment when the organ is clearly visualized and bubble clouds remain within the tissue.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Gannon J, Paul T, Imran KM, et al. Non-Invasive Pancreas Ablation Using Histotripsy: Pre-clinical Safety Study in an In Vivo Porcine Model. Ultrasound Med Biol. 2025. PMID: 41046199. doi:10.1016/j.ultrasmedbio.2025.07.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。